Snowball logo
logo
VX1

VERTEX PHARMACEUTIC (VX1.SG)

€462.20-€14.45  (3.03%)
Estimate
P/E
31.4
EPS
14.72
Beta
0.239
Growth
Revenue, YoY
15.46%
Net income, YoY
9.32%
FCF, YoY
12.17%
About the company
Ticker
VX1
ISIN
US92532F1003
Country
Other
Sector (GICS)
Materials
There is no Profile data available for VX1.SG.

Frequently asked questions

What sector does VERTEX PHARMACEUTIC (VX1.SG) (VX1) operate in?

VERTEX PHARMACEUTIC (VX1.SG) belongs to the Materials sector and operates in the Other industry.

What is VERTEX PHARMACEUTIC (VX1.SG) (VX1) current stock price?

As of the latest data, VERTEX PHARMACEUTIC (VX1.SG) stock price is €462.20, with a previous close of €476.65. VERTEX PHARMACEUTIC (VX1.SG) lost -€14.45 in the last trading session, representing a -3.03% loss.

What is VERTEX PHARMACEUTIC (VX1.SG) (VX1) Earnings Per Share (EPS)?

The trailing EPS is €14.72.

What is VERTEX PHARMACEUTIC (VX1.SG) (VX1) Price-to-Earnings (P/E) ratio?

VERTEX PHARMACEUTIC (VX1.SG) current P/E ratio is 31.4.

What is VERTEX PHARMACEUTIC (VX1.SG) (VX1) EBITDA?

VERTEX PHARMACEUTIC (VX1.SG) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.16 billion.

Does VERTEX PHARMACEUTIC (VX1.SG) (VX1) pay dividends?

No. VERTEX PHARMACEUTIC (VX1.SG) does not pay a dividend.

When is VERTEX PHARMACEUTIC (VX1.SG) (VX1) next earnings report?

VERTEX PHARMACEUTIC (VX1.SG) is expected to release its next earnings report on September 30, 2026.

What is VERTEX PHARMACEUTIC (VX1.SG) (VX1) beta (volatility) score?

VERTEX PHARMACEUTIC (VX1.SG) has a beta of 0.239, indicating lower volatility than the overall market.